Ferraris O - Search Results

1

Serosurveillance study on transmission of H5N1 virus during a 2006 avian influenza epidemic.

Ceyhan M, Yildirim I, Ferraris O, Bouscambert-Duchamp M, Frobert E, Uyar N, Tezer H, Oner AF, Buzgan T, Torunoglu MA, Ozkan B, Yilmaz R, Kurtoglu MG, Laleli Y, Badur S, Lina B. Ceyhan M, et al. Among authors: ferraris o. Epidemiol Infect. 2010 Sep;138(9):1274-80. doi: 10.1017/S095026880999166X. Epub 2010 Jan 22. Epidemiol Infect. 2010. PMID: 20092669

2

Anti N1 cross-protecting antibodies against H5N1 detected in H1N1 infected people.

Frobert E, Bouscambert-Duchamp M, Escuret V, Mundweiler S, Barthélémy M, Morfin F, Valette M, Gerdil C, Lina B, Ferraris O. Frobert E, et al. Among authors: ferraris o. Curr Microbiol. 2010 Jul;61(1):25-8. doi: 10.1007/s00284-009-9571-z. Epub 2009 Dec 25. Curr Microbiol. 2010. PMID: 20033691

3

The NS Segment of H1N1pdm09 Enhances H5N1 Pathogenicity in a Mouse Model of Influenza Virus Infections.

Ferraris O, Casalegno JS, Frobert E, Bouscambert Duchamp M, Valette M, Jacquot F, Raoul H, Lina B, Ottmann M. Ferraris O, et al. Viruses. 2018 Sep 17;10(9):504. doi: 10.3390/v10090504. Viruses. 2018. PMID: 30227598 Free PMC article.

4

Mutations of neuraminidase implicated in neuraminidase inhibitors resistance.

Ferraris O, Lina B. Ferraris O, et al. J Clin Virol. 2008 Jan;41(1):13-9. doi: 10.1016/j.jcv.2007.10.020. Epub 2007 Dec 11. J Clin Virol. 2008. PMID: 18055254 Review.

5

[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].

Ferraris O, Escuret V, Bouscambert-Duchamp M, Lina B, Morfin F. Ferraris O, et al. Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19. Pathol Biol (Paris). 2010. PMID: 20303677 Review. French.

6

Sensitivity of influenza viruses to zanamivir and oseltamivir: a study performed on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice.

Ferraris O, Kessler N, Lina B. Ferraris O, et al. Antiviral Res. 2005 Oct;68(1):43-8. doi: 10.1016/j.antiviral.2005.07.004. Antiviral Res. 2005. PMID: 16125799

7

Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors.

Escuret V, Frobert E, Bouscambert-Duchamp M, Sabatier M, Grog I, Valette M, Lina B, Morfin F, Ferraris O. Escuret V, et al. Among authors: ferraris o. J Clin Virol. 2008 Jan;41(1):25-8. doi: 10.1016/j.jcv.2007.10.019. Epub 2007 Dec 4. J Clin Virol. 2008. PMID: 18055253

8

Importance of viral genomic composition in modulating glycoprotein content on the surface of influenza virus particles.

Moulès V, Terrier O, Yver M, Riteau B, Moriscot C, Ferraris O, Julien T, Giudice E, Rolland JP, Erny A, Bouscambert-Duchamp M, Frobert E, Rosa-Calatrava M, Pu Lin Y, Hay A, Thomas D, Schoehn G, Lina B. Moulès V, et al. Among authors: ferraris o. Virology. 2011 May 25;414(1):51-62. doi: 10.1016/j.virol.2011.03.011. Epub 2011 Apr 5. Virology. 2011. PMID: 21470649 Free article.

9

Evolution of the susceptibility to antiviral drugs of A/H3N2 influenza viruses isolated in France from 2002 to 2005.

Ferraris O, Kessler N, Valette M, Lina B. Ferraris O, et al. Vaccine. 2006 Nov 10;24(44-46):6656-9. doi: 10.1016/j.vaccine.2006.05.050. Epub 2006 Jun 8. Vaccine. 2006. PMID: 16797804

10

Oseltamivir-resistant influenza A(H1N1) viruses in south of France, 2007/2009.

Casalegno JS, Bouscambert-Duchamp M, Caro V, Schuffenecker I, Sabatier M, Traversier A, Valette M, Lina B, Ferraris O, Escuret V. Casalegno JS, et al. Among authors: ferraris o. Antiviral Res. 2010 Aug;87(2):242-8. doi: 10.1016/j.antiviral.2010.05.010. Antiviral Res. 2010. PMID: 20665943

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

59 results

Search Page